Detalhe da pesquisa
1.
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
N Engl J Med
; 389(11): 1009-1022, 2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646702
2.
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper.
Br J Haematol
; 204(4): 1193-1206, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393718
3.
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.
Blood
; 140(16): 1816-1821, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853156
4.
Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone.
Haematologica
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426294
5.
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.
Haematologica
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268439
6.
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study.
Eur J Haematol
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654611
7.
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain.
Eur J Haematol
; 112(5): 701-713, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146208
8.
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.
Eur J Haematol
; 112(4): 547-553, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116695
9.
INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.
Future Oncol
; 20(14): 935-950, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197267
10.
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma.
Blood
; 137(2): 232-237, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443552
11.
Monoclonal gammopathy of increasing significance: time to screen?
Haematologica
; 108(6): 1476-1486, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373250
12.
Multiple myeloma and its treatment contribute to increased platelet reactivity.
Platelets
; 34(1): 2264940, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822056
13.
Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort.
J Oncol Pharm Pract
; 29(2): 299-304, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939868
14.
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.
Br J Haematol
; 198(2): 328-332, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35509237
15.
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.
Br J Haematol
; 197(3): 293-301, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064676
16.
The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease.
Expert Rev Proteomics
; 19(4-6): 235-246, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342226
17.
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
Br J Haematol
; 193(4): 750-760, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650100
18.
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUKfive).
Haematologica
; 106(10): 2694-2706, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910333
19.
Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients.
Eur J Haematol
; 106(4): 563-573, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496996
20.
Management of patients with difficult-to-treat multiple myeloma.
Future Oncol
; 17(16): 2089-2105, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706558